Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Waldman

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Plos One|October 15, 2025
STAG2 regulates polycomb and differentiation in urothelial precursors and bladder cancerYoungrok Park, Wanying Xu, Tianyi Yang, et al.
The Journal of Biological Chemistry|May 5, 2024
STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiformeWanying Xu, Jung-Sik Kim, Tianyi Yang, et al.
Cancer Research|December 18, 2003
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesisRanjan Ray, Rafael Cabal-Manzano, Amy R Moser, et al.
Cancer Research|April 1, 2010
Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenograftsKarine Michaud, David A Solomon, Eric Oermann, et al.
Biochemical and Biophysical Research Communications|July 7, 2010
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brainGiselle Y Lopez, Zachary J Reitman, David Solomon, et al.
Cancer Research|April 3, 2008
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiformeDavid A Solomon, Jung-Sik Kim, Sultan Jenkins, et al.
Cancer Research|October 22, 2009
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cellsMichele I Vitolo, Michele B Weiss, Marta Szmacinski, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
The Journal of Biological Chemistry|November 29, 2012
Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell linesSteffan Vartanian, Carolyn Bentley, Matthew J Brauer, et al.
Journal of Biomolecular Screening|February 22, 2011
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cellsHui-Fang Li, Adam Keeton, Michele Vitolo, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Plos One|October 15, 2025
STAG2 regulates polycomb and differentiation in urothelial precursors and bladder cancerYoungrok Park, Wanying Xu, Tianyi Yang, et al.
The Journal of Biological Chemistry|May 5, 2024
STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiformeWanying Xu, Jung-Sik Kim, Tianyi Yang, et al.
Cancer Research|December 18, 2003
Up-regulation of fibroblast growth factor-binding protein, by beta-catenin during colon carcinogenesisRanjan Ray, Rafael Cabal-Manzano, Amy R Moser, et al.
Cancer Research|April 1, 2010
Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenograftsKarine Michaud, David A Solomon, Eric Oermann, et al.
Biochemical and Biophysical Research Communications|July 7, 2010
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brainGiselle Y Lopez, Zachary J Reitman, David Solomon, et al.
Cancer Research|April 3, 2008
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiformeDavid A Solomon, Jung-Sik Kim, Sultan Jenkins, et al.
Cancer Research|October 22, 2009
Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cellsMichele I Vitolo, Michele B Weiss, Marta Szmacinski, et al.
EMBO Molecular Medicine|January 6, 2010
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsAna M Mendes-Pereira, Sarah A Martin, Rachel Brough, et al.
The Journal of Biological Chemistry|November 29, 2012
Identification of mutant K-Ras-dependent phenotypes using a panel of isogenic cell linesSteffan Vartanian, Carolyn Bentley, Matthew J Brauer, et al.
Journal of Biomolecular Screening|February 22, 2011
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cellsHui-Fang Li, Adam Keeton, Michele Vitolo, et al.
Pageof 6